Anna Ratiu

728 total citations
7 papers, 174 citations indexed

About

Anna Ratiu is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anna Ratiu has authored 7 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Public Health, Environmental and Occupational Health, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anna Ratiu's work include Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Prostate Cancer Treatment and Research (2 papers). Anna Ratiu is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Prostate Cancer Treatment and Research (2 papers). Anna Ratiu collaborates with scholars based in United States, France and United Kingdom. Anna Ratiu's co-authors include Charles Stiller, Emmanuel Désandes, Isabel Izarzugaza, Eva Steliarova‐Foucher, A. Miranda, Birol Emir, Stephen J. Freedland, Sultan Eser, Peter Kaatsch and Arlette Danzon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Anna Ratiu

7 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ratiu United States 4 73 72 59 33 28 7 174
Malek Baassiri United States 6 78 1.1× 125 1.7× 51 0.9× 51 1.5× 16 0.6× 10 234
Joyeeta Guha United Kingdom 7 94 1.3× 163 2.3× 68 1.2× 72 2.2× 22 0.8× 7 304
Gail T. McDonald Canada 8 32 0.4× 47 0.7× 43 0.7× 40 1.2× 15 0.5× 17 317
Florencia Moreno Argentina 9 76 1.0× 87 1.2× 34 0.6× 70 2.1× 12 0.4× 16 248
Pamela Egan United States 9 120 1.6× 98 1.4× 54 0.9× 99 3.0× 11 0.4× 32 284
Revathi Rajagopal Malaysia 10 43 0.6× 38 0.5× 46 0.8× 30 0.9× 14 0.5× 24 266
Ulla Martinsson Sweden 10 79 1.1× 97 1.3× 54 0.9× 92 2.8× 28 1.0× 24 302
Charlotte Demoor‐Goldschmidt France 10 80 1.1× 115 1.6× 66 1.1× 86 2.6× 26 0.9× 44 309
Rajiv Panikkar United States 7 30 0.4× 41 0.6× 43 0.7× 97 2.9× 17 0.6× 14 258
Karen Bartley United States 10 123 1.7× 84 1.2× 113 1.9× 75 2.3× 36 1.3× 27 336

Countries citing papers authored by Anna Ratiu

Since Specialization
Citations

This map shows the geographic impact of Anna Ratiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ratiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ratiu more than expected).

Fields of papers citing papers by Anna Ratiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ratiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ratiu. The network helps show where Anna Ratiu may publish in the future.

Co-authorship network of co-authors of Anna Ratiu

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ratiu. A scholar is included among the top collaborators of Anna Ratiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ratiu. Anna Ratiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Deitelzweig, Steven, Amiee Kang, Cristina Russ, et al.. (2021). EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS. Journal of the American College of Cardiology. 77(18). 1593–1593. 1 indexed citations
2.
Deitelzweig, Steve, Amiee Kang, Cristina Russ, et al.. (2021). Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs. The American Journal of Cardiology. 163. 43–49. 7 indexed citations
3.
Freedland, Stephen J., Rickard Sandin, Birol Emir, et al.. (2021). Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration. Cancer Medicine. 10(23). 8570–8580. 46 indexed citations
4.
Freedland, Stephen J., Rickard Sandin, Birol Emir, et al.. (2021). Survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study.. Journal of Clinical Oncology. 39(6_suppl). 46–46. 2 indexed citations
5.
Castillo, Jorge J., et al.. (2021). Real-world treatment patterns, adherence, costs, and healthcare resource utilization associated with Waldenström macroglobulinemia in the United States.. Journal of Clinical Oncology. 39(15_suppl). e18766–e18766. 1 indexed citations
6.
Steliarova-Foucher, E., Peter Kaatsch, Vera Pompe‐Kirn, et al.. (2006). Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978–1997): Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 42(13). 1915–1951. 41 indexed citations
7.
Stiller, Charles, et al.. (2006). Cancer incidence and survival in European adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 42(13). 2006–2018. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026